This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Three consumer stocks are drawing fresh analyst attention this week as earnings season approaches. Barclays raised its price target on Five Below (NASDAQ:FIVE) ahead of its report next week, while Canaccord Genuity lifted targets on both Ulta Beauty (NASDAQ:ULTA) and Nature’s Sunshine Products (NASDAQ:NATR), the latter reporting results today. The moves reflect growing conviction in the underlying momentum of all three businesses, though the analyst cases vary meaningfully in their urgency and upside.
| Ticker | Company | Firm | Old Rating | New Rating | Old Target | New Target | Current Price | One-Line Takeaway |
|---|---|---|---|---|---|---|---|---|
| FIVE | Five Below | Barclays | Equal Weight | Equal Weight | $193 | $211 | $219.82 | Target raised but stock already trades above the new level; watch Q4 report March 18 |
| ULTA | Ulta Beauty | Canaccord | Buy | Buy | $674 | $799 | $642.22 | Aggressive target raise signals confidence in market share recovery and international expansion |
| NATR | Nature’s Sunshine | Canaccord | Buy | Buy | $22 | $29 | $25.13 | Target lifted ahead of Q4 results due today; momentum in digital and Asia-Pacific driving the bull case |
The Analysts’ Cases
Barclays kept its Equal Weight rating on Five Below while lifting its price target to $211 from $193. The firm acknowledges that the dollar-store segment continues to benefit from favorable external trends, including value-conscious consumer behavior, but notes that market expectations already appear elevated. That measured stance is notable given Five Below’s strong recent execution: the company posted a 14.3% comparable sales increase in Q3 and raised its full-year guidance. Barclays appears to be flagging that much of the good news may already be reflected in the share price.
Canaccord’s Buy-rated thesis on Ulta Beauty is more assertive. The firm raised its target to $799 from $674, citing continued sales growth, margin expansion, and earnings gains as the company regains market share and begins expanding internationally. Analysts are specifically watching holiday performance, share trends across mass and prestige beauty, promotional activity, and initial fiscal 2026 guidance when Ulta reports results on March 12.
For Nature’s Sunshine, Canaccord updated its models ahead of Q4 results and raised its target to $29 from $22, maintaining its Buy rating. The firm is expecting another quarter of robust sales growth and is focused on regional performance, the innovation pipeline, growth-driving initiatives, and early fiscal 2026 outlook. Nature’s Sunshine reports today after the market close.
Company Snapshot and Recent Performance
Five Below operates 1,907 stores across 44 states and has been one of the standout performers in specialty retail over the past year. The stock has gained 16.7% year to date and is up 167.94% over the past year, trading at $219.82 as of March 9. That puts the stock above Barclays’ new $211 target, which is itself a meaningful signal about near-term expectations. The company’s Q3 revenue of $1.038 billion beat estimates by 5.57%, and adjusted diluted EPS of $0.68 came in well ahead of the $0.26 consensus estimate. Full-year guidance calls for net sales of $4.62 billion to $4.65 billion and adjusted EPS of $5.71 to $5.89.
Ulta Beauty has pulled back from recent highs, trading at $642.22 after slipping 5.14% over the past week and 6.97% over the past month. Still, the stock is up 6.15% year to date and has more than doubled over the past year, gaining 80.69%. The company’s Q3 revenue of $2.858 billion beat estimates by 5.70%, with comparable store sales up 6.3% driven by a 3.8% increase in average ticket and 2.4% increase in transactions. The company’s acquisition of Space NK, adding 84 stores across the UK and Ireland, marks its first international footprint.
Nature’s Sunshine is the smallest of the three, with a market cap just over $443 million. The stock trades at $25.13, up 16.45% year to date and 72.48% over the past year. Q3 revenue of $128.3 million beat the $120.3 million estimate, and adjusted EBITDA surged 42% year over year to $15.2 million. Digital sales grew 52% year over year, and the company’s Asia-Pacific segment showed particular strength, with Japan and China both growing more than 30%.
Why the Move Matters Now
The timing of these target revisions is deliberate. Ulta Beauty reports March 12 after the close, and Five Below follows on March 18 after the market. Nature’s Sunshine reports today after the close. Analysts are positioning their models before results arrive, and the direction of those revisions matters: all three targets moved higher, even if the degree of conviction differs.
Canaccord’s $799 target on Ulta implies meaningful upside from current levels, while Barclays’ $211 target on Five Below sits below where the stock is currently trading, making it more of a confirmation of quality than a call to action. For Nature’s Sunshine, the $29 target from Canaccord is close to the stock’s 52-week high of $28.14, suggesting the analyst sees the recent run as justified and potentially still has room ahead if Q4 delivers.
Ulta’s forward P/E of 23x and Five Below’s forward P/E of 32x reflect the premium investors are already paying for growth in both names. Nature’s Sunshine trades at a forward P/E of 24x with an EV/EBITDA of just 8.86x, which looks relatively modest for the growth rate it has been delivering.
Context and Analyst Framing
Ulta Beauty carries a $3 billion share repurchase program with approximately $2 billion remaining, consistent cash generation, and a business model that has proven resilient across beauty cycles. Five Below’s stock currently trades above Barclays’ revised $211 target. Nature’s Sunshine has a smaller float and limited analyst coverage compared to the other two names. Earnings reports from all three companies over the next eight days are expected to include initial fiscal 2026 guidance.
Key Risks to Watch
- Tariff exposure for Five Below: The company explicitly acknowledged tariff risk on merchandise sourced outside the United States in its guidance, which could pressure margins if trade policy tightens further.
- Consumer spending pressure for Ulta: Analysts flagged that consumer wallets remain pressured and value-seeking behavior is intensifying, which could weigh on average ticket growth even if traffic holds.
- Concentration and coverage risk for Nature’s Sunshine: With limited analyst coverage and a relatively small float of approximately 12.2 million shares, NATR can be volatile around earnings and news events.
This is not personalized financial advice. 247wallst.com and its writers do not own the stocks mentioned. Always do your own due diligence before investing.
